Go to main content
logo unither pharmaceuticals site internet
  • 简体中文 | ZH-HANS
  • Français | FR
  • Português | PT-BR
  • Services
    • Manufacturing
      • Technology Transfer & Scale-Up
      • Commercial batches manufacturing
      • Small-batch manufacturing – rare diseases
      • Small-batch manufacturing – veterinary
    • Development
      • Formulation Development
      • Analytical Development
      • Clinical Batch & Placebo Manufacturing
      • Stability Studies
      • Ophthalmic Development
      • Co-Development Program
      • Regulatory Support
    • Out-licensing
      • Medical devices
      • Drugs
      • Product List
  • Solutions
    • By technology
      • Sterile liquids
      • Blow-Fill-Seal (BFS)
      • Multi-Dose
      • Non-sterile liquids
      • Stick-Pack
      • Spray
      • Bottle
      • Other
      • Solids & Semi-Solids
    • By therapeutic area
      • Ophthalmology
      • ENT
      • Injectable
      • Respiratory
      • Rare Diseases
      • Other Therapeutic Areas

    • Breakthrough Solutions
      • Euroject® – BFS Injectable
      • Carragelose – Viral Infection
      • Sol-Gel™ – Ophthalmology
      • Uniflash® – Oro-mucosal
    • Turnkey products
      • Medical devices
      • Drugs
      • Product List
  • The Group
    • About Us
      • About Us
      • Vision and Innovation
      • Executive Committee
      • History
    • Global presence
      • Overview
      • In France
      • In Brazil
      • In the United States
      • In China
    • Commitment
      • Cap 2030: our CSR strategy
      • Responsible Purchasing
    • News
      • News
      • Agenda
      • Press Area
  • Careers
    • Careers
      • Working at Unither
      • Our job opportunities
  • Inspire Hub
  • Contact
Site search
Press Enter to start the search
News
News

News

 Category filters

 Filter by categories:

 Select categories

Articles in category: News

Corporate

Construction of a New Industrial Facility in Gannat

CDMO’s Challenges for Developing Oral Suspensions for Children

Synergism between oral paracetamol and nefopam in a murine model of postoperative pain

News

Innovative Ophthalmic products

News

UNITHER invests 68 million euros in the innovative project: Euroject®

Corporate News

Ophthalmics at Butantã site, São Paulo

News

Press Release – Acquisition of the Carragelose Portfolio by Unither Pharmaceuticals

News

Join us at Europharm SMC

Article News

Marinomed Biotech AG: Extraordinary general meeting approves sale of Carragelose division

patient ingérant une Unidose sans conservateur

News

Leading CDMO for Eye Drops and Sterile Drug Manufacturing

News

Unither Manufacturing LLC 10th anniversary

News

$106 Million to Modernize Rochester Facility

1 2 3 … 6 Next >

Services

  • Manufacturing
  • Development
  • Out-licensing

Solutions

  • By technology
  • By therapeutic area
  • Breakthrough Solutions
  • Product notices

The group

  • About Us
  • Vision and Innovation
  • Executive Committee
  • History

Inspire Hub

Follow Us

  • X (opens in a new tab)
  • LinkedIn (opens in a new tab)
  • YouTube (opens in a new tab)

Newsletter Signup

Newsletter
  • Legal links menu
  • Code of Conduct
  • Procurement Policy
  • Legal Notice
  • Privacy Policy
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.